Global Animal Therapeutics and Diagnostics Market 2022-2028

June 2022 | 74 pages | ID: G8F42169B631EN
Gen Consulting Company

Abstracts

Diagnostics are the crucial link between the two key strategies for good health, prevention and treatment. Animal diagnostics are critical for animal health, identifying health issues before they are otherwise able to be detected and supporting faster diagnosis and treatment planning. According to Gen Consulting Company, the global animal therapeutics and diagnostics market is set to achieve an incremental growth of USD 23 billion, acelerating at a CAGR of almost 6.1% during the forecast period 2022-2028.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global animal therapeutics and diagnostics market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the animal therapeutics and diagnostics industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, end user, and region. The global market for animal therapeutics and diagnostics can be segmented by product: diagnostics, feed additives, therapeutics, vaccines. Globally, the therapeutics segment made up the largest share of the animal therapeutics and diagnostics market. Animal therapeutics and diagnostics market is further segmented by end user: companion animals, production animals. The production animals segment captured the largest share of the market in 2021. Based on region, the animal therapeutics and diagnostics market is segmented into: Asia Pacific, Europe, North America, Rest of the World (RoW). According to the research, North America had the largest share in the global animal therapeutics and diagnostics market.

By product:

• diagnostics
• feed additives
• therapeutics
• vaccines

By end user:

• companion animals
• production animals

By region:

• Asia Pacific
• Europe
• North America
• Rest of the World (RoW)

The diagnostics market is further segmented into analyzers and consumables, imaging equipment and related, rapid test kits. The analyzers and consumables segment was the largest contributor to the global animal therapeutics and diagnostics market in 2021. Furthermore, the pharmaceuticals/therapeutics market has been categorized into allergy and respiratory drugs, anti-infectives, anti-inflammatories and analgesics, metabolic drugs, parasiticides, psychotropics, others. The parasiticides segment is estimated to account for the largest share of the global animal therapeutics and diagnostics market. The feed additives market is further divided into amino acids, medicinal additives, nutritional supplements, vitamins and minerals. The amino acids segment held the largest share of the global animal therapeutics and diagnostics market in 2021 and is anticipated to hold its share during the forecast period.

The report also provides a detailed analysis of several leading animal therapeutics and diagnostics market vendors that include Ajinomoto Co., Inc., BASF SE, Bayer AG, Boehringer Ingelheim GmbH, China National BlueStar (Group) Co, Ltd., DSM Nutritional Products AG, Elanco Animal Health Incorporated, Evonik Industries AG, IDEXX Laboratories, Inc., Merck Animal Health, The Mosaic Company, Virbac SA, Zoetis Inc., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global animal therapeutics and diagnostics market.
• To classify and forecast the global animal therapeutics and diagnostics market based on product, end user, region.
• To identify drivers and challenges for the global animal therapeutics and diagnostics market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global animal therapeutics and diagnostics market.
• To identify and analyze the profile of leading players operating in the global animal therapeutics and diagnostics market.

Why Choose This Report

• Gain a reliable outlook of the global animal therapeutics and diagnostics market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY PRODUCT

Diagnostics
Feed additives
Therapeutics
Vaccines

PART 6. MARKET BREAKDOWN BY END USER

Companion animals
Production animals

PART 7. MARKET BREAKDOWN BY REGION

Asia Pacific
Europe
North America
Rest of the World (RoW)

PART 8. KEY COMPANIES

Ajinomoto Co., Inc.
BASF SE
Bayer AG
Boehringer Ingelheim GmbH
China National BlueStar (Group) Co, Ltd.
DSM Nutritional Products AG
Elanco Animal Health Incorporated
Evonik Industries AG
IDEXX Laboratories, Inc.
Merck Animal Health
The Mosaic Company
Virbac SA
Zoetis Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER